Childhood rhabdomyosarcoma

Seminars in Pediatric Surgery

Volumn 15, Issue 1, 2006, Pages 57-62

  Rodeberg, David ^a   Paidas, Charles ^b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c TAMPA GENERAL HOSPITAL   (United States)

Author keywords

Alveolar rhabdomyosarcoma; Botryoid; Children; Embryonal; Risk based therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; TOPOTECAN; VINCRISTINE;

CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHILDHOOD CANCER; HISTOPATHOLOGY; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA;

EID: 31744436418     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2005.11.009     Document Type: Article

References (42)

1. W.M. Crist, L. Garnsey, M.S. Beltangady Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee J Clin Oncol 8 1990 443 452
2. S.L. Spunt, T.E. Lobe, A.S. Pappo Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma J Pediatr Surg 35 2000 309 316
3. W.M. Crist, J.R. Anderson, J.L. Meza Intergroup rhabdomyosarcoma study-IV results for patients with nonmetastatic disease J Clin Oncol 19 2001 3091 3102
4. D.M. Parham Pathologic classification of rhabdomyosarcomas and correlations with molecular studies Mod Pathol 14 2001 506 514
5. H. Scrable, D. Witte, H. Shimada Molecular differential pathology of rhabdomyosarcoma Genes Chromosomes Cancer 1 1989 23 35
6. T. Gordon, A. McManus, J. Anderson Cytogenetic abnormalities in 42 rhabdomyosarcoma a United Kingdom Cancer Cytogenetics Group Study Med Pediatr Oncol 36 2001 259 267
7. L. De Zen, A. Sommaggio, E.S. d'Amore Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88 J Clin Oncol 15 1997 1198 1205
8. F.G. Barr Molecular genetics and pathogenesis of rhabdomyosarcoma J Pediatr Hematol Oncol 19 1997 483 491
9. G. Merlino, L.J. Helman Rhabdomyosarcoma working out the pathways Oncogene 18 1999 5340 5348
10. S. Bortolozzi, A. Bisognin, C. Romualdi Novel genes, possibly relevant for molecular diagnosis or therapy of human rhabdomyosarcoma, detected by genomic expression profiling Gene 348 2005 65 71
11. D. Schofield, T.J. Triche eDNA microarray analysis of global gene expression in sarcomas Curr Opin Oncol 14 2002 406 411
12. I. Leuscher, I. Langhans, R. Schmitz p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study Pediatr Dev Pathol 6 2003 128 135
13. K. Scotland, M.C. Manara, G. Nicoletti Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors Cancer Res 65 2005 3868 3876
14. D.S. Dickens, T.P. Cripe Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts J Pediatr Hematol Oncol 25 2003 709 714
15. D. Williamson, Y.J. Lu, T. Gordon Relationship between MYCN copy number and expression in rhabdomyosarcoma and correlation with adverse prognosis in the alveolar subtype J Clin Oncol 23 2005 880 888
16. D.M. Hays, W. Lawrence Jr, M. Wharam Primary reexcision for patients with "microscopic residual" tumor following initial excision of sarcomas of trunk and extremity sites J Pediatr Surg 24 1989 5 10
17. H.L. Neville, R.J. Andrassy, T.E. Lobe Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997) J Pediatr Surg 35 2000 317 321
18. E.S. Wiener, J.R. Anderson, J.I. Ojimba Controversies in the management of paratesticular rhabdomyosarcoma is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 10 2001 146 152
19. D.A. Rodeberg, C.N. Paidas, T.T. Lobe Surgical Principles for children adolescents with newly diagnosed rhabdomyosarcoma a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group Sarcoma 6 2002 111 122
20. E. Wiener Second look operations in children in group III and IV, rhabdomyosarcoma Med Pediatr Oncol 18 1990 408
21. E. Wiener, W. Lawrence, D. Hays Complete response or not complete response? Second look operations are the answer in children with rhabdomyosarcoma Proc Am Soc Clin Oncol 10 1991 316
22. M.P. La Quaglia The surgical management of metastases in pediatric cancer Semin Pediatr Surg 2 1993 75 82
23. D. Rodeberg, C. Arndt, J. Breneman Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV J Pediatr Surg 40 2005 256 262
24. C.A. Arndt, W.M. Crist Common musculoskeletal tumors of childhood and adolescence N Engl J Med 341 1999 342 352
25. A.S. Pappo, J.R. Anderson, W.M. Crist Survival after relapse in children and adolescents with rhabdomyosarcoma a report from the Intergroup Rhabdomyosarcoma Study Group J Clin Oncol 17 1999 3487 3493
26. L.R. Mandell Ongoing progress in the treatment of childhood rhabdomyosarcoma Oncology 7 1993 71 83 discussion 84-6, 89-90.
27. R.B. Raney, J.R. Anderson, F.G. Barr Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V J Pediatr Hematol Oncol 23 2001 215 220
28. J. Breneman, J. Anderson, S. Donaldson Prognostic factors and outcome in children with metastatic rhabdomyosarcoma a report from the Intergroup Rhabdomyosarcoma Study IV Int J Radiat Oncol Biol Phys 51 suppl 1 2001 118 A-210, [Abstract]
29. W.M. Crist, L. Garnsey, M.S. Beltangady Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee J Clin Oncol 8 1990 443 452
30. A.S. Pappo, E. Etcubanas, V.M. Santana A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma Cancer 71 1993 2119 2125
31. K.S. Baker, J.R. Anderson, M.P. Link Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma results from the Intergroup Rhabdomyosarcoma Study IV J Clin Oncol 18 2000 2427 2434
32. S.L. Spunt, L.M. Smith, F.B. Ruymann Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome a report from the soft tissue sarcoma committee of the children's oncology group Clin Cancer Res 10 2004 6072 6079
33. P.P. Breitfeld, E. Lyden, R.B. Raney Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy a report from the Intergroup Rhabdomyosarcoma Study Group J Pediatr Hematol Oncol 23 2001 225 233
34. E. Sandler, E. Lyden, F. Ruymann Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma a report from the Intergroup Rhabdomyosarcoma Study Group Med Pediatr Oncol 37 2001 442 448
35. J.C. Breneman, E. Lyden, A.S. Pappo Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma a report from the Intergroup Rhabdomyosarcoma Study IV J Clin Oncol 21 2003 78 84
36. A.S. Pappo, E. Lyden, J. Breneman Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma an intergroup rhabdomyosarcoma study J Clin Oncol 19 2001 213 219
37. D.O. Walterhouse, E.R. Lyden, P.P. Breitfeld Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma a Children's Oncology Group study J Clin Oncol 22 2004 1398 1403
38. H.M. Maurer, E.A. Gehan, M. Beltangady The Intergroup Rhabdomyosarcoma Study-II Cancer 71 1993 1904 1922
39. S.L. Wolden, J.R. Anderson, W.M. Crist Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma a report from the Intergroup Rhabdomyosarcoma Studies I to III J Clin Oncol 17 1999 3468 3475
40. L. Mandell, F. Ghavimi, T. Peretz Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy J Clin Oncol 8 1990 1536 1542
41. S.S. Donaldson, J. Meza, J.R. Anderson Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma a report from the IRSG Int J Radiat Oncol Biol Phys 51 2001 718 728
42. W. Lawrence Jr, J.R. Anderson, E.A. Gehan Children's Cancer Study Group Pretreatment TNM staging of childhood rhabdomyosarcoma a report of the Intergroup Rhabdomyosarcoma Study Group Pediatric Oncology Group Cancer 80 1997 1165 1170